Guardant Health, Inc. Proceeds from Stock Issuance 2016-2026 | GH
Beta
What is Guardant Health, Inc.'s current proceeds from stock issuance?
Guardant Health, Inc. (GH) annual proceeds from stock issuance for 2025 was $19.2M, a 516.32% increase from 2024. Guardant Health, Inc. proceeds from stock issuance for the quarter ending March 31, 2026 was $3.7M.
What was Guardant Health, Inc.'s proceeds from stock issuance in 2024?
Guardant Health, Inc. annual proceeds from stock issuance for 2024 was $3.1M, a 99.37% decline from 2023.
What was Guardant Health, Inc.'s proceeds from stock issuance in 2023?
Guardant Health, Inc. annual proceeds from stock issuance for 2023 was $493.1M, a 18685.37% increase from 2022.
What is Guardant Health, Inc.'s 5-year proceeds from stock issuance CAGR?
Guardant Health, Inc. proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 15.07% from FY2020 to FY2025, going from $9.5M to $19.2M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+15.1%
FY2020
$9.5M
→
FY2025
$19.2M
16171819202122232425
5 years selected
Company: Guardant Health, Inc.Ticker: GHSector: HealthcareIndustry: Services-Medical LaboratoriesView company profile →